REDWOOD CITY, Calif. – Proteus Digital Health believes it takes adherence to the next level with Proteus Discover, an ingestible sensor that’s co-encapsulated with a patient’s medicine.
The sensor records time of ingestion and other personalized data, communicating with a small wearable patch worn by the patient. That data can be viewed by patients through a mobile app, and by physicians and care teams through an online portal.
“Care teams are often unsure whether the patient’s lack of progress is due to medication error or adherence,” said Praveen Raja, vice president and head of medical science/solutions at Proteus Digital Health. “This is a way to understand what’s happening at home between visits to the doctor and plan interventions. Proteus can help the patient take control of their disease—they know what to take and when to take it.”
The use of Proteus Discover has resulted in positive outcomes, including a reduction in blood pressure and LDL cholesterol in clinical trial patients with chronic hypertension and Type 2 diabetes, according to the company. The sensor is being used at Children’s Health in Dallas, and Barton Health in South Lake Tahoe, Calif.
Raja said that more than 50% of prescribed medication is not taken as directed, resulting in an escalation of conditions and, often, readmission, which drives up the cost of health care.
“When CMS instituted penalties for readmission, many health systems became interested in using Proteus to help with medication adherence,” said Raja.